Tech Company Financing Transactions
Arboretum LifeSciences Funding Round
.406 Ventures, Amgen Ventures and F-Prime Capital participated in a $30 million Series A venture round for Arboretum LifeSciences. The round closed on 10/7/2026.
Transaction Overview
Company Name
Announced On
10/7/2026
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to build scientific and operational infrastructure, expand product development, accelerate the adoption of clinically-indicated genetic testing, and scale its longitudinal molecular research network.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
245 Main Street
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
We're genomic data scientists, software engineers, and researcher clinicians united by one goal: delivering precision medicine to the millions who need it most. Our mission is to transform how we prevent and treat common diseases by making precision medicine accessible to everyone who needs it.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony Philippakis
Chief Technical Officer
Craig Lancaster
President
Clare Bernard
VP - Bus. Development
Danielle Ciofani
VP - Finance
Liam Casey
VP - R & D
Andrea Ramirez
Browse more venture capital transactions:
Prev: 10/7/2026: Netsec venture capital transaction
Next: 10/7/2026: Nearhuman venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs